4//SEC Filing
Humer Franz B 4
Accession 0001209191-18-055385
CIK 0001737287other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 5:32 PM ET
Size
8.3 KB
Accession
0001209191-18-055385
Insider Transaction Report
Form 4
Humer Franz B
Director
Transactions
- Purchase
Common Stock
2018-10-15$18.00/sh+30,000$540,000→ 30,000 total - Conversion
Series A Convertible Preferred Stock
2018-10-15−14,261→ 0 total→ Common Stock (74,870 underlying) - Conversion
Common Stock
2018-10-15+74,870→ 104,870 total
Footnotes (1)
- [F1]The Series A Convertible Preferred Stock converted on a 5.25-for-1 basis and had no expiration date.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001548072
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 5:32 PM ET
- Size
- 8.3 KB